Qussai Salamah, MD
Pulmonary Disease · Detroit, MINPI 1447554654
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 22 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Bard Access Systems, Inc. at 24.4% of the total. That places this record below the midpoint for pulmonary disease clinicians in MI, where the typical reported total is $1,164.
Across 22 payments — averaging $34.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bard Access Systems, Inc.$183
- United Therapeutics Corporation$163
- Sanofi$92
- CSL Behring$84
- Sunovion Pharmaceuticals Inc.$61
- Actelion Pharmaceuticals US, Inc.$56
- plus $111 from 4 others
What the payments were for
- Food & beverage$751100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bard Access Systems, Inc. | 2 | $183 |
| United Therapeutics Corporation | 4 | $163 |
| Sanofi | 1 | $92 |
| CSL Behring | 3 | $84 |
| Sunovion Pharmaceuticals Inc. | 6 | $61 |
| Actelion Pharmaceuticals US, Inc. | 2 | $56 |
| Inspire Medical Systems, Inc. | 1 | $44 |
| Johnson & Johnson | 1 | $28 |
| Mylan Specialty L.p. | 1 | $23 |
| AstraZeneca | 1 | $16 |
How this compares
$751 in reported general payments places this provider in the 40th percentile of 463 pulmonary disease providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Detroit
- Michael SimoffDetroit$149K
- Avi CohenDetroit$59K
- Labib Gilles DebianeDetroit$22K
- Meilan HanAnn Arbor$779K
- Njira LugogoAnn Arbor$741K
- Gustavo Cumbo NacheliGrand Rapids$724K
- Gary FergusonLivonia$601K
- Justin OldhamAnn Arbor$392K
- Mounir GhaliWyoming$371K
- Kevin FlahertyAnn Arbor$328K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.